Similar Papers

Paper Title
Journal
Date
Author
New Horizons in Chemotherapy: Platforms for Combinations in First-Line Advanced Non-small Cell Lung Cancer
Rogerio C Lilenbaum
Journal of Thoracic Oncology | VOL. 3
Rogerio C LilenbaumRogerio C Lilenbaum
01 Jun 2008
Regularity of prescriptions for intermediate and advanced lung cancer based on latent structure combined with association rules
...
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica | VOL. 47
, et. al. ...
01 Jan 2021
Treatment of advanced lung cancer by external beam radiotherapy and high dose rate (HDR) brachytherapy
Janusz Skowronek ... Witold Młynarczyk
Reports of Practical Oncology & Radiotherapy | VOL. 6
Janusz Skowronek, et. al.Janusz Skowronek ... Witold Młynarczyk
01 Jan 2001
Erlotinib combined with chemotherapy in treatment of advanced squamous cell lung cancer: a clinical analysis
-
15 Dec 2015
View more papers

More From: International Journal of Radiation Oncology*Biology*Physics

Paper Title
Journal
Date
Author
Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580.
Vinai Gondi ... Lisa A Kachnic
International Journal of Radiation Oncology*Biology*Physics | VOL. 121
Vinai Gondi, et. al.Vinai Gondi ... Lisa A Kachnic
01 Feb 2025
Issue Highlights
-
International Journal of Radiation Oncology*Biology*Physics | VOL. 121
--
01 Feb 2025
Issue Highlights
-
International Journal of Radiation Oncology*Biology*Physics | VOL. -
--
01 Jan 2025
Combined molecular subclass and immune phenotype correlate to atezolizumab plus radiation therapy response in invasive bladder cancer: BPT-ART Phase II study
Yoshiyuki Nagumo ... Hiroyuki Nishiyama
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Yoshiyuki Nagumo, et. al.Yoshiyuki Nagumo ... Hiroyuki Nishiyama
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.